Background and Aims
Fibromyalgia syndrome (FMS) is a condition characterised by chronic widespread muscle pain, fatigue, memory, concentration difficulties, headaches, bowel symptoms and insomnia. Most pain services deliver generic Pain Management Programmes (PMP) , regardless of pain diagnosis (1), although some advocate diagnosis-specific self-management programmes.

Methods
We collected demographic and patient-reported outcome measurement (PROM) data for the period 2011-2016. All patients were divided into two groups: FMS group (n=182) and non-FMS group for all other diagnoses (n=427). All patients completed a battery of PROMs (TSK, CPAQ, HADS and ODI) prior (Q1) and on completion (Q2) of the PMP. Chi-square and T-test tests were applied for results. 
Results
     The FMS patient group was significantly more female than the non-FMS group (1), but otherwise, the two groups were demographically identical. Non-FMS patients scored significantly higher (p<0.05) on fear of movement (TSK) as compared to the FMS group of patients (2). The FMS group of patients demonstrated higher anxiety, depression, acceptance of pain(CPAQ) and perceived disability (Oswestry index). However, these differences were not statistically significant( p>0.05). (2)-(4)
Both groups demonstrated statistically significant improvement in all patient reported outcome measures (TSK, CPAQ, HADS Anxiety, HADS Depression , Oswestry index) after attending the generic PMP. There were no differences in the magnitude of pre-post change between FMS and non-FMS groups. (2)-(4)

Conclusion
FMS patients attending our generic, outpatient PMP were more female and demonstrated less fear of movement as compared to non-FMS patients. At the completion of the PMP, both FMS and non-FMS patients showed significant and identical improvements in outcome measures. These findings do not suggest that there is a need for a diagnosis-specific PMP for FMS patients.

DO FIBROMYALGIA SYNDROME (FMS) PATIENTS NEED A DIAGNOSIS-SPECIFIC PAIN MANAGEMENT PROGRAMME (PMP)?